申请人:Basak Arindrajit
公开号:US20100234364A1
公开(公告)日:2010-09-16
Compounds are provided that act as potent antagonists of the CCR2 or CCR9 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2 and CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, CCR9-mediated diseases, as controls in assays for the identification of CCR2 antagonists, and as controls in assays for the identification of CCR9 antagonists.
提供了作为CCR2或CCR9受体强效拮抗剂的化合物。动物实验表明,这些化合物对于治疗炎症非常有效,而炎症是CCR2和CCR9的典型疾病。这些化合物通常是芳基磺酰胺衍生物,在制药组合物、治疗CCR2介导疾病的方法、治疗CCR9介导疾病的方法、作为CCR2拮抗剂鉴定的检测中的对照物,以及作为CCR9拮抗剂鉴定的检测中的对照物中非常有用。